235 related articles for article (PubMed ID: 10753845)
1. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.
Padró T; Ruiz S; Bieker R; Bürger H; Steins M; Kienast J; Büchner T; Berdel WE; Mesters RM
Blood; 2000 Apr; 95(8):2637-44. PubMed ID: 10753845
[TBL] [Abstract][Full Text] [Related]
2. [Angiogenesis in patients with hematologic malignancies].
Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.
Perez-Atayde AR; Sallan SE; Tedrow U; Connors S; Allred E; Folkman J
Am J Pathol; 1997 Mar; 150(3):815-21. PubMed ID: 9060819
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
[TBL] [Abstract][Full Text] [Related]
5. Evidence of increased angiogenesis in patients with acute myeloid leukemia.
Hussong JW; Rodgers GM; Shami PJ
Blood; 2000 Jan; 95(1):309-13. PubMed ID: 10607717
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide for the treatment of acute myeloid leukemia.
Steins MB; Bieker R; Padró T; Kessler T; Kienast J; Berdel WE; Mesters RM
Leuk Lymphoma; 2003 Sep; 44(9):1489-93. PubMed ID: 14565649
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of angiogenesis in the bone marrow of acute leukemia patients].
Ye XJ; Wang LJ; Lin MF; Ding W
Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):486-9. PubMed ID: 12921610
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival.
Kuzu I; Beksac M; Arat M; Celebi H; Elhan AH; Erekul S
Leuk Lymphoma; 2004 Jun; 45(6):1185-90. PubMed ID: 15359999
[TBL] [Abstract][Full Text] [Related]
9. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow microvessel density and its prognostic significance in AML.
Rabitsch W; Sperr WR; Lechner K; Chott A; Prinz E; Valent P; Kalhs P
Leuk Lymphoma; 2004 Jul; 45(7):1369-73. PubMed ID: 15359635
[TBL] [Abstract][Full Text] [Related]
11. Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia.
AbdElAal Asmaa A; Afify RA; Zaher AE; ElGammal MM; Atef AM
Hematology; 2015 Oct; 20(9):504-10. PubMed ID: 25885121
[TBL] [Abstract][Full Text] [Related]
12. Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort.
Brune MM; Stüssi G; Lundberg P; Vela V; Heim D; Manz MG; Haralambieva E; Pabst T; Banz Y; Bargetzi M; Grobholz R; Fehr M; Cogliatti S; Ossenkoppele GJ; Löwenberg B; Rudolf CB; Li Q; Passweg J; Mazzuchelli L; Medinger M; Tzankov A;
Ann Hematol; 2021 May; 100(5):1169-1179. PubMed ID: 33704530
[TBL] [Abstract][Full Text] [Related]
13. [Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia].
Wang C; Chen FY; Zhu JS; Xu YP; Han JY; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):845-8. PubMed ID: 15634546
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of thalidomide in patients with acute myeloid leukemia.
Steins MB; Padró T; Bieker R; Ruiz S; Kropff M; Kienast J; Kessler T; Buechner T; Berdel WE; Mesters RM
Blood; 2002 Feb; 99(3):834-9. PubMed ID: 11806984
[TBL] [Abstract][Full Text] [Related]
15. Endostatin serum level in acute myeloid leukemia.
Wrobel T; Mazur G; Kapelko K; Kuliczkowski K
Neoplasma; 2005; 52(2):182-4. PubMed ID: 15800718
[TBL] [Abstract][Full Text] [Related]
16. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor.
de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E
Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392
[TBL] [Abstract][Full Text] [Related]
17. Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance.
Pulè MA; Gullmann C; Dennis D; McMahon C; Jeffers M; Smith OP
Br J Haematol; 2002 Sep; 118(4):991-8. PubMed ID: 12199777
[TBL] [Abstract][Full Text] [Related]
18. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.
Kern W; Haferlach T; Schoch C; Loffler H; Gassmann W; Heinecke A; Sauerland MC; Berdel W; Buchner T; Hiddemann W
Blood; 2003 Jan; 101(1):64-70. PubMed ID: 12393605
[TBL] [Abstract][Full Text] [Related]
19. Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis.
Lin B; Zhao K; Yang D; Bai D; Liao Y; Zhou Y; Yu Z; Yu X; Guo Q; Lu N
J Cell Physiol; 2019 Feb; 234(2):1913-1924. PubMed ID: 30105796
[TBL] [Abstract][Full Text] [Related]
20. [Study on the role of angiogenesis and related factors in leukemias].
Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
